scPharmaceuticals Inc. (SCPH) Misses Q3 EPS by 4c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q3 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.4 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Nike names former Pfizer CFO David Denton as new finance chief